Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 3 studies | 22% ± 4% | |
epithelial cell | 3 studies | 27% ± 1% | |
ciliated cell | 3 studies | 23% ± 2% | |
GABAergic neuron | 3 studies | 32% ± 4% | |
glutamatergic neuron | 3 studies | 39% ± 4% | |
dendritic cell | 3 studies | 20% ± 1% | |
oligodendrocyte | 3 studies | 18% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 28% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2863.44 | 2642 / 2642 | 100% | 64.26 | 705 / 705 |
esophagus | 100% | 2677.77 | 1445 / 1445 | 100% | 42.05 | 183 / 183 |
breast | 100% | 2472.32 | 459 / 459 | 100% | 57.06 | 1117 / 1118 |
prostate | 100% | 2371.30 | 245 / 245 | 100% | 56.20 | 501 / 502 |
stomach | 100% | 1875.06 | 358 / 359 | 100% | 33.89 | 286 / 286 |
intestine | 100% | 2657.86 | 966 / 966 | 99% | 33.99 | 524 / 527 |
uterus | 100% | 2893.38 | 170 / 170 | 99% | 39.58 | 456 / 459 |
thymus | 100% | 2349.10 | 653 / 653 | 99% | 44.02 | 601 / 605 |
ovary | 100% | 2366.38 | 180 / 180 | 99% | 24.84 | 427 / 430 |
lung | 99% | 2006.79 | 575 / 578 | 100% | 37.29 | 1151 / 1155 |
skin | 100% | 3168.59 | 1808 / 1809 | 99% | 48.40 | 466 / 472 |
pancreas | 99% | 1587.43 | 324 / 328 | 99% | 32.64 | 177 / 178 |
bladder | 100% | 2843.90 | 21 / 21 | 98% | 30.26 | 493 / 504 |
adrenal gland | 100% | 2486.93 | 257 / 258 | 96% | 40.32 | 221 / 230 |
kidney | 99% | 1468.94 | 88 / 89 | 96% | 34.26 | 868 / 901 |
liver | 95% | 918.11 | 214 / 226 | 95% | 22.00 | 386 / 406 |
adipose | 100% | 2349.81 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3024.27 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 40.42 | 29 / 29 |
spleen | 100% | 2204.41 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 45.47 | 45 / 45 |
muscle | 100% | 3239.54 | 802 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 35.13 | 77 / 80 |
heart | 96% | 2011.13 | 825 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 91% | 1888.49 | 845 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0000209 | Biological process | protein polyubiquitination |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0006338 | Biological process | chromatin remodeling |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0007346 | Biological process | regulation of mitotic cell cycle |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0030336 | Biological process | negative regulation of cell migration |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0033503 | Cellular component | HULC complex |
GO_0005730 | Cellular component | nucleolus |
GO_0000151 | Cellular component | ubiquitin ligase complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0042393 | Molecular function | histone binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0002039 | Molecular function | p53 binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0140850 | Molecular function | histone H2B C-terminal K residue ubiquitin ligase activity |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0003730 | Molecular function | mRNA 3'-UTR binding |
GO_0005515 | Molecular function | protein binding |
Gene name | RNF20 |
Protein name | E3 ubiquitin-protein ligase BRE1A (BRE1-A) (hBRE1) (EC 2.3.2.27) (RING finger protein 20) (RING-type E3 ubiquitin transferase BRE1A) E3 ubiquitin protein ligase (EC 2.3.2.27) |
Synonyms | BRE1A |
Description | FUNCTION: Component of the RNF20/40 E3 ubiquitin-protein ligase complex that mediates monoubiquitination of 'Lys-120' of histone H2B (H2BK120ub1). H2BK120ub1 gives a specific tag for epigenetic transcriptional activation and is also prerequisite for histone H3 'Lys-4' and 'Lys-79' methylation (H3K4me and H3K79me, respectively). It thereby plays a central role inb histone code and gene regulation. The RNF20/40 complex forms a H2B ubiquitin ligase complex in cooperation with the E2 enzyme UBE2A or UBE2B; reports about the cooperation with UBE2E1/UBCH are contradictory. Required for transcriptional activation of Hox genes. Recruited to the MDM2 promoter, probably by being recruited by p53/TP53, and thereby acts as a transcriptional coactivator. Mediates the polyubiquitination of isoform 2 of PA2G4 in cancer cells leading to its proteasome-mediated degradation. .; FUNCTION: (Microbial infection) Promotes the human herpesvirus 8 (KSHV) lytic cycle by inducing the expression of lytic viral genes including the latency switch gene RTA/ORF50. . |
Accessions | ENST00000374819.6 ENST00000466817.1 ENST00000389120.8 C9JWJ4 C9J0A5 C9JXC9 Q5VTR2 Q05DC0 A0PJJ6 ENST00000479306.5 |